antibody development in Australia

We are an immuno-oncology company - developer of novel 
prostate cancer diagnostics and therapeutics with the MiCheck test and Miltuximab patented antibody.

Patrys Limited's principal focus is on the development of antibody therapies for major market opportunities in the oncology area.